CHRONOMATE- altrenogest solution

Страна: Соединенные Штаты

Язык: английский

Источник: NLM (National Library of Medicine)

Активный ингредиент:

ALTRENOGEST (UNII: 2U0X0JA2NB) (ALTRENOGEST - UNII:2U0X0JA2NB)

Доступна с:

Ceva Santé Animale

Администрация маршрут:

ORAL

Тип рецепта:

OTC

Терапевтические показания :

ChronoMate™ (altrenogest) SOLUTION 0.22% (2.2 mg/mL) FOR ORAL USE IN ANIMALS ONLY Drug Facts: Active ingredients: Altrenogest Solution 0.22% (2.2 mg/mL) Use: For synchronization of estrus in sexually mature gilts that have had at least one estrous cycle. Treatment with altrenogest solution 0.22% results in estrus (standing heat) 4 to 9 days after completion of the 14-day treatment period. Caution: Federal law prohibits extra-label use of this drug to enhance food and/or fiber production in animals. Do Not Use: In gilts having a previous or current history of uterine inflammation (i.e., acute, subacute or chronic endometritis).

Статус Авторизация:

Abbreviated New Animal Drug Application

Характеристики продукта

CHRONOMATE- ALTRENOGEST SOLUTION
CEVA SANTÉ ANIMALE
----------
CHRONOMATE™
(ALTRENOGEST)
SOLUTION 0.22%
(2.2 mg/mL)
FOR ORAL USE IN ANIMALS ONLY
DRUG FACTS:
ACTIVE INGREDIENTS: Altrenogest Solution 0.22% (2.2 mg/mL)
USE: For synchronization of estrus in sexually mature gilts that have
had at least one
estrous cycle. Treatment with altrenogest solution 0.22% results in
estrus (standing
heat) 4 to 9 days after completion of the 14-day treatment period.
CAUTION: Federal law prohibits extra-label use of this drug to enhance
food and/or fiber
production in animals.
DO NOT USE: In gilts having a previous or current history of uterine
inflammation (i.e.,
acute, subacute or chronic endometritis).
WARNINGS
KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN.
USER/HANDLER SAFETY: Avoid skin contact. Wear vinyl, neoprene or
nitrile protective
gloves when handling this product. DO NOT USE LATEX GLOVES
Pregnant women or women who suspect they are pregnant should not
handle
ChronoMate (altrenogest) solution 0.22%. Women of childbearing age
should exercise
extreme caution when handling this product. Accidental absorption
could lead to a
disruption of the menstrual cycle or prolongation of pregnancy. Wash
off accidental
spillage on the skin immediately with soap and water.
PEOPLE WHO SHOULD NOT HANDLE THIS PRODUCT:
1. Women who are or suspect they are pregnant.
2. Anyone with thrombophlebitis or thromboembolic disorders or with a
history of these
events.
3. Anyone with cerebral-vascular or coronary-artery disease.
4. Women with known or suspected carcinoma of the breast.
5. People with known or suspected estrogen-dependent neoplasia.
6. Women with undiagnosed vaginal bleeding.
7. People with benign or malignant tumors which developed during the
use of oral
contraceptives or other estrogen-containing products.
8. Anyone with liver dysfunction or disease.
ACCIDENTAL EXPOSURE: Altrenogest is readily absorbed from contact with
the skin. In
addition, this oil based product can penetrate porous gloves.
Altrenogest should not